KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) FCF Margin (2016 - 2025)

Historic FCF Margin for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to 44.45%.

  • Amgen's FCF Margin rose 54700.0% to 44.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 32.08%, marking a year-over-year increase of 127700.0%. This contributed to the annual value of 31.1% for FY2024, which is 49900.0% up from last year.
  • According to the latest figures from Q3 2025, Amgen's FCF Margin is 44.45%, which was up 54700.0% from 20.82% recorded in Q2 2025.
  • Amgen's FCF Margin's 5-year high stood at 54.94% during Q2 2023, with a 5-year trough of 3.53% in Q4 2023.
  • For the 5-year period, Amgen's FCF Margin averaged around 29.8%, with its median value being 32.45% (2021).
  • As far as peak fluctuations go, Amgen's FCF Margin tumbled by -302400bps in 2023, and later skyrocketed by 449000bps in 2024.
  • Quarter analysis of 5 years shows Amgen's FCF Margin stood at 36.82% in 2021, then decreased by -8bps to 33.76% in 2022, then tumbled by -90bps to 3.53% in 2023, then skyrocketed by 1273bps to 48.43% in 2024, then dropped by -8bps to 44.45% in 2025.
  • Its FCF Margin stands at 44.45% for Q3 2025, versus 20.82% for Q2 2025 and 12.03% for Q1 2025.